A detailed history of Franklin Resources Inc transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 28,640 shares of AMPH stock, worth $1.43 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28,640
Previous 25,670 11.57%
Holding current value
$1.43 Million
Previous $1.13 Million 1.6%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$38.65 - $43.48 $114,790 - $129,135
2,970 Added 11.57%
28,640 $1.15 Million
Q1 2024

May 13, 2024

SELL
$42.85 - $63.45 $38,307 - $56,724
-894 Reduced 3.37%
25,670 $1.13 Million
Q4 2023

Feb 09, 2024

SELL
$44.49 - $62.93 $8,275 - $11,704
-186 Reduced 0.7%
26,564 $1.64 Million
Q3 2023

Nov 13, 2023

SELL
$45.51 - $65.0 $38,046 - $54,340
-836 Reduced 3.03%
26,750 $1.23 Million
Q2 2023

Aug 11, 2023

BUY
$35.77 - $58.38 $645,755 - $1.05 Million
18,053 Added 189.37%
27,586 $1.59 Million
Q1 2023

May 12, 2023

SELL
$27.99 - $37.92 $1,651 - $2,237
-59 Reduced 0.62%
9,533 $357,000
Q4 2022

Feb 10, 2023

BUY
$27.93 - $31.27 $223 - $250
8 Added 0.08%
9,592 $268,000
Q3 2022

Nov 14, 2022

SELL
$27.56 - $37.75 $75,541 - $103,472
-2,741 Reduced 22.24%
9,584 $269,000
Q2 2022

Aug 11, 2022

SELL
$29.79 - $42.29 $134,710 - $191,235
-4,522 Reduced 26.84%
12,325 $429,000
Q1 2022

May 13, 2022

SELL
$22.96 - $36.45 $230,196 - $365,447
-10,026 Reduced 37.31%
16,847 $605,000
Q4 2021

Feb 11, 2022

BUY
$18.14 - $23.29 $6,965 - $8,943
384 Added 1.45%
26,873 $626,000
Q3 2021

Nov 12, 2021

BUY
$17.83 - $21.49 $285,173 - $343,711
15,994 Added 152.4%
26,489 $504,000
Q2 2021

Aug 13, 2021

BUY
$17.11 - $20.92 $2,207 - $2,698
129 Added 1.24%
10,495 $212,000
Q1 2021

May 13, 2021

BUY
$17.21 - $20.65 $178,398 - $214,057
10,366 New
10,366 $190,000

Others Institutions Holding AMPH

About Amphastar Pharmaceuticals, Inc.


  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $2.44B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.